Why is Bliss GVS Pharma falling/rising?

As of 15-Sep, Bliss GVS Pharma Ltd is experiencing a slight decline in its stock price, currently at 152.20, reflecting a decrease of 0.25 or 0.16%. The stock has been underperforming recently, with a consecutive fall over the last two days resulting in a total decline of 1.36%. Additionally, the stock has shown negative returns over the past week and month, with declines of 1.52% and 9.91%, respectively. Although it has outperformed the sector by 0.29% today, the overall trend indicates a decrease in investor participation, as evidenced by an 8.73% drop in delivery volume compared to the five-day average. The stock is trading at a premium relative to its peers, and while it has generated a positive return of 13.71% over the past year, profits have decreased by 3.6%, suggesting a potential concern for investors.
In the broader market context, the stock's short-term performance is notably weaker compared to the benchmark, with the Sensex gaining 1.24% over the past week while Bliss GVS Pharma has declined by 1.52%. This divergence highlights the stock's struggles in a generally positive market environment. Despite its long-term outperformance against the BSE500 over three years, one year, and three months, the recent negative trends in both short-term returns and declining investor interest may be contributing to the stock's current downward movement.